EIR Ventures — Full Portfolio
24 tracked investments · listed companies and verified rows first
Advancing potentially best-in-class therapeutics for myeloproliferative neoplasms.
BiotechCopenhagen, US
Garrett Winslow(Executive Officer)Lori Firmani(Executive Officer)Hans T. Schambye(Executive Officer, Director)
BoardChristopher Cain(Director)Carl Goldfischer(Director)Peter Harwin(Director)
Board seatStephan Christgau· per SEC Form D · $64.2M raise · filed Nov 2020
Co-investorsAccess BiotechnologyBay City Capital
Moleculent develops biological discovery and disease understanding tools for scientists.
AI & Machine LearningBiotechDeep Tech
Fredrik Roos(CTO & Co-founder)
Co-investorsARCH Venture Partners
Pretzel Therapeutics develops therapeutics targeting bioenergetic dysfunction and mitochondrial disease by addressing defects in mitochondrial DNA function and gene expression.
BiotechDeep TechHealthtechMedical Devices
Michal Minczuk(Co-Founder)Gabriel Martinez(Chief Scientific Officer & Co-Founder)Claes Gustafsson(Co-Founder)Maria Falkenberg(Co-Founder)Nils-Göran Larsson(Co-Founder)Jay Parrish(Chief Executive Officer & Chairman of the Board)in
Co-investorsARCH Venture PartnersCambridge Innovation CapitalGV (Google Ventures)HealthCap
ArgusEye develops LSPR-based biosensor systems for real-time monitoring and analytics of bioprocesses in biopharmaceutical development and manufacturing.
BiotechDeep TechHardware
Co-investorsVoima Ventures
Attgeno is a pharmaceutical company developing Supernitro, a therapy focused on the targeted delivery of nitric oxide to treat critically ill patients.
BiotechDigital HealthHealthtechMedical DevicesStockholm, SE
Lars E. Gustafsson(Co-founder (deceased))
BoardMagnus Persson(Chairman of the Board)
Co-investorsHadean Ventures
Swedish biopharmaceutical company developing novel potassium-competitive acid blockers for faster and more effective treatment of GERD.
Cinclus Pharma is a clinical-stage pharmaceutical company developing small molecules for gastric acid related diseases.
BiotechHealthtech
Christer Ahlberg(CEO)
Copenhagen-based oncology company developing treatments for acute myeloid leukemia and other cancer types based on University of Copenhagen research.
Entrilia provides an integrated platform supporting the complete lifecycle of fund operations, including financial reporting, investor management, and operational workflows for fund managers.
AI & Machine LearningEnterprise SoftwareFintechSaaS
Co-investorsWatertower Ventures Management, Llc
Damora Therapeutics is a biotechnology company developing subcutaneous biologics as targeted, disease-modifying treatments for patients with mutant calreticulin (mutCALR)-driven myeloproliferative neoplasms such as essential thrombocythemia and myelofibrosis.
BiotechMedical Devices
Jennifer Jarrett(Chief Executive Officer & Board Director)Sherwin Sattarzadeh(Chief Operating Officer)Becker Hewes(Chief Medical Officer)Garrett Winslow(General Counsel)Jim Baker(Chief Corporate Affairs Officer)Brian Burkavage(Senior Vice President, Finance)
Co-investorsHadean VenturesM VenturesSEED Capital DenmarkSunstone CapitalYsios CapitalMaverick Ventures+1 more
Gutcrine is a Danish biotech developing pharmabiotics derived from gut microbiome hormone synthesis, aimed at the prevention and treatment of cardio-metabolic disorders.
BiotechDeep TechHealthtechLongevityCopenhagen, DK
Oluf Pedersen(CSO & Co-founder)Yong Fan(COO & Co-founder)Tobias Horneman-Thielcke(CEO)in
Henlez is an early-stage biotech company working in the dermatology space.
BiotechHealthtech
Danish biotech developing non-opioid restorative treatments for chronic pain, hearing loss and sensory neuron disorders.
Co-investorsIndaco Venture Partners
Co-investorsMedical Incubator Japan K.K.
IOBiotech appears to be a biotech company focused on oncology, with a founder who has extensive experience in cancer drug development and clinical advancement from roles at Roche, Eli Lilly, and leading academic cancer centers.
BiotechMedical Devices
Dr. Dhingra
Co-investorsAvoro Capital AdvisorsKurma PartnersRA CapitalSamsara BioCapitalSunstone CapitalVivo Capital+2 more
Mitochondrial biology-focused biotech founded by leading academics in the field, developing novel therapeutics.
Purpose Pharma is a European pharmaceutical company that develops and commercializes products for rare diseases and specialty care in areas of high unmet medical need.
BiotechHealthtechStockholm, SE
Co-investorsIndustrifonden
Swedish digital health platform implementing value-based care monitoring for outpatient surgery to improve quality, patient satisfaction and healthcare efficiency.
The page is a domain listing/marketplace tool (ExpiredDomains.com) that aggregates expired and expiring domain names across many TLDs and lets users filter them by SEO authority, keywords, backlinks, and brand potential.
Marketing TechSaaS
SACRA Therapeutics is a drug discovery company developing therapeutics that target the RNA epitranscriptome, with a focus on oncology.
BiotechHealthtechLund, SE
Scenic Biotech develops modifier therapy, a genetic medicine approach that targets secondary functions in the genome to neutralize the impact of disease-causing mutations.
AI & Machine LearningBiotechDeep TechDigital HealthHealthtech
Co-investorsBioMedPartnersOxford Science EnterprisesBioGeneration VenturesInkef
Gothenburg University spin-out developing first-in-class sortilin inhibitor therapies targeting metastasis and growth of aggressive cancers.
Strike Pharma develops a targeted lipid nanoparticle (LNP) delivery technology for in vivo CAR therapies aimed at autoimmune diseases and cancer.
BiotechLongevity
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.